Extended course of varenicline successful in late-quitters
By Nigel Praities
Smokers who struggle with their initial quit attempt may benefit from being offered an extended course of smoking cessation treatment, according to a US study.
The data, presented at the European Society of Cardiology this week, showed 35% of ‘late-quitters subsequently managed to quit following a second 12 week course of varenicline, despite quitting late in the course of a standard 12-week treatment course. This compared with the 23% of late-quitters who were put onto placebo after their initial quit attempt.